{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T06:08:52Z","timestamp":1773814132786,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2018,7,10]]},"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>While fixed-dose combinations (FDC) can improve adherence, they may add complexity to the prescribing\/dispensing process, potentially increasing risk of medication errors. This study aimed to determine if prescriptions for antihypertensive FDCs increase the risk of therapeutic duplication and drug\u2013drug interactions (DDI).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective observational study used administrative pharmacy claims data from the Irish Primary Care Reimbursement Service. Prescriptions dispensed to adults in 2015 were included if they contained an antihypertensive FDC, or the same drugs prescribed separately. The outcomes were therapeutic duplication and potentially serious DDI involving FDC drugs. Relative risk (RR) of these outcomes, adjusted for prescription and patient factors, was determined using generalised linear models with Poisson distributions and propensity score matching.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>This study included 307 833 FDC prescriptions (67.0%) and 151\u2009632 separate component prescriptions. Half of patients prescribed FDCs were female with a mean age of 67.1 (SD 12.5) years and, compared with separate component prescriptions, FDCs were less often coprescribed with other cardiovascular medications. Therapeutic duplication occurred in 0.8% of prescriptions, most often involving calcium channel blockers, and 10.6% contained a DDI (most often amlodipine and simvastatin). The RR of therapeutic duplication on FDC prescriptions compared with separate component prescriptions was 1.46 (95% CI 1.17 to 1.83) and the adjusted RR was 2.06 (95% CI 1.64 to 2.60). For DDIs, there was no significant difference between FDC and separate component prescriptions after confounder adjustment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study found FDCs were associated with increased risk of duplication. When considering prescribing FDCs, this safety consideration should be weighed against potential benefits.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2018-313492","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T09:26:10Z","timestamp":1547544370000},"page":"204-209","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Fixed-dose combination antihypertensives and risk of medication errors"],"prefix":"10.1136","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9838-3625","authenticated-orcid":false,"given":"Frank","family":"Moriarty","sequence":"first","affiliation":[{"name":"HRB Centre for Primary Care Research, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Bennett","sequence":"additional","affiliation":[{"name":"Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5896-5783","authenticated-orcid":false,"given":"Tom","family":"Fahey","sequence":"additional","affiliation":[{"name":"HRB Centre for Primary Care Research, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,8,2]]},"reference":[{"key":"2025092100462818000_105.3.204.1","unstructured":"European Medicines Agency Committee for Medicinal Products for Human Use (2017) Guideline on Clinical Development of Fixed Combination Medicinal Products. London, UK."},{"key":"2025092100462818000_105.3.204.2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(17)30553-6","article-title":"Uses of polypills for cardiovascular disease and evidence to date","volume":"389","author":"Huffman","year":"2017","journal-title":"Lancet"},{"key":"2025092100462818000_105.3.204.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.08.033"},{"key":"2025092100462818000_105.3.204.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.277064"},{"key":"2025092100462818000_105.3.204.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2010.03.001"},{"key":"2025092100462818000_105.3.204.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60240-2"},{"key":"2025092100462818000_105.3.204.7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1715163513500208","article-title":"Reducing pill burden and helping with medication awareness to improve adherence","volume":"146","author":"Farrell","year":"2013","journal-title":"Can Pharm J"},{"key":"2025092100462818000_105.3.204.8","first-page":"CD010316","article-title":"First-line combination therapy versus first-line monotherapy for primary hypertension","volume":"1","author":"Garj\u00f3n","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025092100462818000_105.3.204.9","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.3.3.167"},{"key":"2025092100462818000_105.3.204.10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/0310057X0903700401","article-title":"The ability of anaesthetists to identify generic medications from trade names","volume":"37","author":"Bramley","year":"2009","journal-title":"Anaesth Intensive Care"},{"key":"2025092100462818000_105.3.204.11","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.9.1065"},{"key":"2025092100462818000_105.3.204.12","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.7.785"},{"key":"2025092100462818000_105.3.204.13","doi-asserted-by":"publisher","DOI":"10.1258\/jhsrp.2007.007011"},{"key":"2025092100462818000_105.3.204.14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296"},{"key":"2025092100462818000_105.3.204.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2310-7"},{"key":"2025092100462818000_105.3.204.16","first-page":"652","article-title":"Medication Utilization Patterns and Hypertension-Related Expenditures among Patients Who Were Switched from Fixed-Dose To Free-Combination Antihypertensive Therapy","volume":"33","author":"Hess","year":"2008","journal-title":"P T"},{"key":"2025092100462818000_105.3.204.17","first-page":"CD009868","article-title":"Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases","volume":"3","author":"Bahiru","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025092100462818000_105.3.204.18","doi-asserted-by":"publisher","DOI":"10.1002\/pst.433"},{"key":"2025092100462818000_105.3.204.19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12874-017-0338-0","article-title":"Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance","volume":"17","author":"Nguyen","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"2025092100462818000_105.3.204.20","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1200"},{"key":"2025092100462818000_105.3.204.21","unstructured":"Irish Medication Safety Network. Briefing Document on Sound-Alike Look-Alike Drugs (SALADs), 2010."},{"key":"2025092100462818000_105.3.204.22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/qjmed\/hcp052","article-title":"Medication errors: what they are, how they happen, and how to avoid them","volume":"102","author":"Aronson","year":"2009","journal-title":"QJM"},{"key":"2025092100462818000_105.3.204.23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs.2010.046318"},{"key":"2025092100462818000_105.3.204.24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140708","article-title":"Fixed-dose combination drug approvals, patents and market exclusivities compared to single active ingredient pharmaceuticals","volume":"10","author":"Hao","year":"2015","journal-title":"PLoS One"},{"key":"2025092100462818000_105.3.204.25","doi-asserted-by":"publisher","DOI":"10.1023\/B:JOMS.0000021518.60670.10"},{"key":"2025092100462818000_105.3.204.26","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0504-5"},{"key":"2025092100462818000_105.3.204.27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00228-014-1786-7","article-title":"Drug-drug interaction software in clinical practice: a systematic review","volume":"71","author":"Roblek","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"2025092100462818000_105.3.204.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2016-006422"},{"key":"2025092100462818000_105.3.204.29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2013.00091","article-title":"Determinants of patient adherence: a review of systematic reviews","volume":"4","author":"Kardas","year":"2013","journal-title":"Front Pharmacol"},{"key":"2025092100462818000_105.3.204.30","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(17)30558-5","article-title":"Putting polypills into practice: challenges and lessons learned","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2018-313492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:46:36Z","timestamp":1758440796000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2018-313492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,2]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,1,15]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/heartjnl-2018-313492"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2018-313492","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,2]]}}}